{"a":[{"_":"Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition","$":{"href":"/pharma/sanofi-lay-229-blueprint-medicines-staff-close-cambridge-offices-following-acquisition","hreflang":"en"}}]}

Summary

Sanofi is laying off 229 employees from Blueprint Medicines in Cambridge, Massachusetts as part of post-acquisition integration under new CEO Belén Garijo. The workforce reduction represents the first major restructuring disclosed following Sanofi's acquisition of Blueprint Medicines.